[144] Ionis Pharmaceuticals, Inc. SEC Filing

Rhea-AI Filing Summary

Notice of proposed sale under Rule 144: The filing reports the proposed sale of 28,000 common shares, acquired the same day by exercise of stock options and paid in cash. The broker named is UBS Financial Services, Inc. (11 Madison Avenue, New York). The aggregate market value of the shares is listed as $1,680,000.00, with 159,391,229 shares outstanding and an approximate sale date of 09/03/2024 on NASDAQ. The filer reports no securities sold in the past three months and includes the standard signature representation re: material nonpublic information and Rule 10b5-1 plan language.

Positive

• Full disclosure of transaction mechanics: acquisition date, nature (option exercise), payment method, broker, and planned sale date are provided
• No reported sales in prior three months, suggesting this may be a one-off disposition rather than ongoing insider selling

Negative

• Issuer and filer identity fields are incomplete in the form content, limiting context about the specific insider or corporate role
• No detail on whether a Rule 10b5-1 plan applies beyond the generic representation, so the filing does not clarify pre-arranged trading instructions

Insights

Securities Analyst

TL;DR: Insider exercised options and intends to sell 28,000 shares via UBS on NASDAQ, representing a routine Rule 144 notice.

The filing documents a same-day option exercise and proposed sale of 28,000 common shares with an aggregate market value of $1.68M. The transaction is routed through a major broker and scheduled for 09/03/2024. No prior sales in the past three months are reported, which may indicate this is an isolated disposition rather than part of a recurring selling pattern. The filing includes the required representation that the seller is not aware of undisclosed material adverse information.

Corporate Governance Expert

TL;DR: This is a standard Rule 144 notice documenting an option exercise and planned market sale; disclosures appear routine.

The notice provides necessary mechanics: acquisition date, nature of acquisition (stock option exercise), payment in cash, broker details, and outstanding share count. The absence of reported sales in the prior three months and the inclusion of the signature representation align with typical compliance practices. No governance concerns or material adverse events are disclosed in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Avenue 4th Floor New York NY 10010	28000	1680000.00	159391229	09/03/2024	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	09/03/2024	Exercise of Stock Option	Issuer			28000	09/03/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 for IONS report?

It reports a proposed sale of 28,000 common shares acquired by exercise of stock options and paid in cash, with an aggregate market value of $1.68M.

When is the approximate date of sale listed on the Form 144?

The approximate sale date is listed as 09/03/2024.

Through which broker will the shares be sold?

The broker named is UBS Financial Services, Inc. at 11 Madison Avenue, New York, NY.

Does the filing report any securities sold by the same person in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

How many shares outstanding does the filing list?

The filing lists 159,391,229 shares outstanding.